karen clint marketing portfolio

MARKETING PORTFOLIO

Nearly a decade ago, TECHLAB developed a marketing and sales partnership with Alere. Part of our agreement was for Alere to develop and represent TECHLAB products within their global branding infrastructure.

Upon further evaluation, TECHLAB came to realize that our company was missing out on the value of building and maintaining our own brand identity, both at the product and corporate levels. With this revelation came a new commitment to investing resources into building our brands and telling our stories through our own voice, rooted in science, research, and development and speaking directly to our core audience of clinicians and physicians. Since 2014, TECHLAB has put significantly increased energy into reclaiming our branding and marketing efforts.

This publication presents TECHLAB’s recent brand development and marketing work and is organized by product category. As we do with our diagnostics, we test the results of our marketing and continue to refine and enhance these efforts to deliver ever improving results.

Believing in the Value of Investing in our Brands

From ads to selling aids, TECHLAB has built a powerful marketing engine to support its superior technology. TECHLAB Marketing is responsible for identifying, anticipating, and satisfying customer requirements. The goals of our marketing efforts are to:

• Raise product awareness • Generate product interest • Build product desire • Facilitate product sales, and • Measure results for improved effectiveness

TECHLAB yields measurable results with market share gain, customer retention, brand awareness, loyalty, and trust through multi-channel marketing strategies and tactics. These channels largely include e-mail marketing, print collateral, direct mail, web marketing, tradeshows, advertising, and public relations.

Powerful Marketing Tools for Superior Diagnostics

Multi-Channel Marketing

PUBLIC RELATIONS

E-MAIL MARKETING

PRINT COLLATERAL/DIRECT MAIL

ADVERTISING

TRADESHOW

WEB

INTESTINAL INFLAMMATION PRODUCT MARKETING

A CUSTOM DESIGNED 20-FOOT BOOTH provided an integrated video monitor and numerous product and information display areas.

POSTCARD MAILERS sent to likely DDW participants before the show built product interest and invited participants to the booth.

COLORFUL BUTTONS worn by booth staff encouraged visitors to engage.

ADVERTISING in the DDW Daily News during the show reinforced the look and messaging of the postcard mailer.

SIGNAGE reminded visitors to register for a test kit greeted counter visitors.

TEST KIT VOUCHERS were provided to booth visitors who registered.

May 3–6, 2014Exhibit Dates: May 4–6, 2014McCormick Place, Chicago, Illinois

Unlock IBD/IBS diagnosis with non-invasive lactoferrin testing for intestinal inflammation.

Please visit us at BOOTH 2756www.techlab.com | [email protected] 25 YEARS OF EXCELLENCE IN MEDICAL DIAGNOSTICS

1-800-TECHLAB

Are you including lactoferrin testing in your routine diagnostics?

DDW 2014Digestive Disease Week

® Unlock IBD/IBS diagnosis with non-invasive lactoferrin testing for intestinal inflammation.

Please visit us at BOOTH 2756

The TECHLAB Logo, and TECHLAB are trademarks of TECHLAB, Inc. © 2014 TECHLAB, Inc. All rights reserved.

TECHLAB’s DDW 2014 tradeshow highlighted two lactoferrin products: IBD-SCAN® and IBD EZ VUE®. We chose a distinctive palette of white, gray, gold, and our corporate maroon, and combined this palette with clean shapes inspired by the test kits themselves to establish the modern, clinical visual identity for our booth and associated marketing materials.

DDW2014 Tradeshow

ASK MEHOW TO

SCREEN FORIBS/IBD!

Register

HERE to get your

IBD-SCAN® or IBD EZ VUE®

Evaluation Test Kit!

IBD-SCAN® IBD EZ VUE®This voucher is redeemable for one IBD-SCAN® OR one IBD EZ VUE® lactoferrin evaluation test kit. Check the circle on the kit of your choice.

Limit 1 test kit per facility. Facility must be licensed to perform moderate or high complexity testing. This voucher is not redeemable for cash. This voucher expires on December 31, 2014.

| Lactoferrin Test KitVOUCHER

OR

Quantitative Assay Rapid Qualitative Assay

DDW2014See reverse for how to redeem

PROMO CODE

2001 Kraft Drive | Blacksburg, VA 24060 | USA

Get a reliable indication of

intestinal inflammation

with lactoferrin testing.

www.techlab.comCELEBRATING 25 YEARS OF EXCELLENCE IN MEDICAL DIAGNOSTICS

Find out how

INSIDE!

Is it IBS or IBD?

Take the proactive approach to identify the condition.

Get a reliable indication of intestinal inflammation with lactoferrin testing.

CELEBRATING 25 YEARS OF EXCELLENCE IN MEDICAL DIAGNOSTICS

www.techlab.com

is it IBS?Take the proactive approach

to identify the condition.



www.techlab.com

or is it IBD?After the show, TECHLAB sent booth visitors a special mailing containing expanded information on lactoferrin and a fun, promotional item.

AN ENGAGING ENVELOPE enticed recipients to open it.

A REMOVABLE HOLOGRAM MAGNET attached to the front of a brochure changed images and wording upon tilting to compellingly illustrate the question that lactoferrin testing helps to answer.

A MULTI-PAGE BROCHURE provided detailed information on how lactoferrin testing works, its clinical advantages, how to order testing, and scientific publications on lactoferrin. The brochure cover and a sample interior spread are shown here.

There are ample national and international publications on the effectiveness of lactoferrin as a biomarker of inflammation. Here are just a few examples.

What evidence-based literature exists on lactoferrin?

S. Kane, W. Sandborn, P. Rufo, A. Zholudev, J. Boone, D. Lyerly, M. Camilleri, and S. Hanauer.Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation.2003. Am J Gastroenterol 98:6. 1309-1314.

M. Parsi, B. Shen, J. Achkar, F. Remzi, J. Goldblum, J. Boone, D. Lin, J. Connor, V. Fazio, and B. Lashner.Fecal lactoferrin for diagnosis of symptomatic patients with ileal pouch-anal anastomosis.2004. Gastroenterology 126. 1280-1286.

T. Walker, M. Land, A. Kartashov, T. Saslowsky, D. Lyerly, J. Boone, and P. Rufo.Fecal lactoferrin is a sensitive and specific marker of disease activity in children and young adults with inflammatory bowel disease.2007. J Pediatr Gastroenterol Nutr 44:4. 414-422.

R. Sidhu, P. Wilson, A. Wright, C. Yau, F. D’Cruz, L. Foye, S. Morley, A. Lobo, M. Mcalindon and D. Sanders.Faecal lactoferrin—a novel test to differentiate between the irritable and inflamed bowel?2010. Aliment Pharmacol Ther 31. 1365-1370.

J. Däbritz, J. Musci, and D. Foell.Diagnostic utility of faecal biomarkers in patients with irritable bowel syndrome.2014. World Journal of Gastroenterol 20:2. 363-375.

Take the proactive approach to identify the condition.

Does your patient suffer from abdominal pain?



www.techlab.com

TECHLAB, 2001 Kraft Dr., Blacksburg, VA 24060, United States

You may unsubscribe or change your contact details at any time.

TECHLAB lactoferrin tests help identify intestinal inflammation quickly and reliably. Learn more at ACG 2014.View this email online if it doesn't display correctly

Does your patient suffer fromABDOMINAL PAIN?

Identify inflammation withLACTOFERRIN TESTING

QUALITATIVELACTOFERRIN TESTS

LEUKO EZ VUE® — Lateral flow format fortesting patients with acute, infectious bowel symptoms

IBD EZ VUE® — Lateral flow format for testingpatients with chronic, non- infectious bowel symptoms

IBD-CHEK® — ELISA format for testing patientswith chronic, non-infectious bowel symptoms

QUANTITATIVELACTOFERRIN TEST IBD-SCAN® — ELISA format for testing patients

with chronic, non-infectious bowel symptoms or to assist inmonitoring quantitative inflammation levels in IBD patients

Visit us at ACG 2014 BOOTH 1207 for aLACTOFERRIN TEST KIT voucher


www.techlab.com | [email protected] TECHLAB Logo, and TECHLAB are trademarks of TECHLAB, Inc.

© 2014 TECHLAB, Inc. All rights reserved.

Subject: Let's talk Lactoferrin at ACG2014 in Philadelphia

0LikeLike TweetTweet 0 ShareShare 0 0 0 SubscribeSubscribe

Let's talk Lactoferrin at ACG2014 in Philadelphia http://app.getresponse.com/archive/erin_708957/Lets-talk-Lacto...

1 of 2 11/25/14, 9:49 AM

Does your patient suffer from ABDOMINAL PAIN?


www.techlab.com

ACG 2014 | Visit us at BOOTH 1207

Identify inflammation with

LACTOFERRIN TESTING

Lateral flow format for testing patients with chronic, non-infectious bowel symptoms

IBD EZ VUE®

Lateral flow format for testing patients with acute, infectious

bowel symptoms

LEUKO EZ VUE®

ELISA format for testing patients with chronic, non-infectious bowel

symptoms or to assist in monitoring quantitative inflammation levels in

IBD patients

IBD-SCAN®

ELISA format for testing patients with chronic, non-infectious bowel symptoms

IBD-CHEK®

All trademarks referenced are trademarks of TECHLAB, Inc. ©2014 TECHLAB, Inc. All rights reserved.

QUALITATIVE LACTOFERRIN TESTS

QUANTITATIVE LACTOFERRIN TEST

Does your patient suffer from ABDOMINAL PAIN?

Identify inflammation with

LACTOFERRIN TESTING

Lateral flow format for testing patients with chronic, non-infectious bowel symptoms

IBD EZ VUE®

Lateral flow format for testing patients with acute, infectious

bowel symptoms

LEUKO EZ VUE®

ELISA format for testing patients with chronic, non-infectious bowel

symptoms or to assist in monitoring quantitative inflammation levels in

IBD patients

IBD-SCAN®

ELISA format for testing patients with chronic, non-infectious bowel symptoms

IBD-CHEK®

QUALITATIVE LACTOFERRIN TESTS

QUANTITATIVE LACTOFERRIN TEST


www.techlab.com | [email protected]

Visit us at ACG 2014 BOOTH 1207 for a LACTOFERRIN TEST KIT voucher

Marketing its full range of lactoferrin products at ACG, TECHLAB introduced categorization by qualitative vs. quantitative formats and gave our abdomen image center stage.

ACG2014 Tradeshow

A FULL PAGE AD placed in a leading professional journal before the show reached a wide audience.

POSTCARD MAILERS sent to likely show participants reinforced the messaging of the journal ad.

A TARGETED E-MAIL BLAST completed the pre-show marketing initiative, building on the journal ad and the postcard mailer and providing immediate links to our website for more information.

THE BOOTH design worked closely with the look and feel of our pre-show marketing materials and provided an integrated video monitor and various product/information display areas.

PROJECT TECHLAB 10x20 ACG Annual Meeting 2014 - view 1

VOUCHER | Lactoferrin Test KitREDEEMABLE FOR ONE LACTOFERRIN TEST KIT OF YOUR CHOICE:*

ACG2014

PROMO CODE

Limit 1 test kit per facility. This voucher is not redeemable for cash. This voucher expires on December 31, 2014.

LEUKO EZ VUE® (QUALITATIVE TEST) IBD EZ VUE® (QUALITATIVE TEST) IBD-CHEK® (QUALITATIVE TEST) IBD-SCAN® (QUANTITATIVE TEST)



3 easy ways to redeem: Onlinetechlab.com/getlactoferrin1 Email

[email protected] Call1-800-TECHLAB 3

All trademarks referenced are trademarks of TECHLAB, Inc. ©2014 TECHLAB, Inc. All rights reserved.

Redeeming facility must be licensed to perform mod-erate or high complexity testing. A confirmation of the facility’s testing license is required prior to shipment.

*

Utilize the benefits of Alere’s on-site product support and technical consultants

An established network of product consultants can provide technical training and operational support of enteric diagnostics for routine use in your laboratory. Dedicated to facilitating the implementation of new assays, these consultants will offer effective training to help speed up the validation process of a new test for use. Expertise is offered on the evaluation and review of data from a laboratory perspective. Our product support team is dedicated to helping achieve efficiency and excellence in clinical practice.

Actual reimbursement may vary. Alere cannot guarantee or promise coverage or payment for any particular item or service from any payer or health benefit plan. It is the individual provider’s responsibility to determine appropriate coding for a particular service. Made in the U.S.A. All products referenced, the TECHLAB Logo, and TECHLAB are trademarks of TECHLAB, Inc., under license. The Alere Logo and Alere are trademarks of the Alere group of companies. © 2014 TECHLAB, Inc. All rights reserved. PN: MCIBD0003 9/14.

IBD EZ VUE®

Moderately Complex25 Test KitOrder Number: 30353 CPT® Code: 83630

LEUKO EZ VUE®

Moderately Complex25 Test KitOrder Number: 30355CPT® Code: 83630

IBD-SCAN®

Highly Complex96 Test KitOrder Number: 30351 CPT® Code: 83631

IBD CHEK®


Find out today how the LACTOFERRIN TESTING suite of products from Alere and TECHLAB®

can enhance your routine diagnostics

Alere Customer Service

Phone: 1-877-441-7440 (if calling within U.S.) 1-321-441-7200 (if calling from outside U.S.)Online: alere.com

“We are using the LEUKO EZ VUE for lactoferrin testing and the staff LOVES it! Not only is it more sensitive than smears, but evening and night shift staff felt much more sure about their results. They felt there was less subjectivity and less chance of a false negative due to lysed WBCs.”Nancy Burdette, Microbiology Laboratory Supervisor, St. Vincent’s East Hospital, Birmingham, Alabama

Developed & manufactured by:Distributed by:

AN ENGAGING VIDEO about lactoferrin testing played continuously at the booth during the show.

PRODUCT SHEETS available at the booth detailed the technical support available for lactoferrin testing.

VOUCHERS obtained at the booth could be redeemed for a test kit.

NON-INVASIVE LACTOFERRIN TESTING

Suffering from abdominal pain?Ask your doctor about

options


www.techlab.com

QUICK, RELIABLE, COST-EFFECTIVEThe TECHLAB Logo, and TECHLAB are trademarks of TECHLAB, Inc. © 2014 TECHLAB, Inc. All rights reserved.LEUKO EZ VUE®

IBD SCAN®

IBD EZ VUE®

TECHLAB, 2001 Kraft Dr., Blacksburg, VA 24060, United States

You may unsubscribe or change your contact details at any time.

View this email online if it doesn't display correctly


Request LACTOFERRIN TESTING todayfrom your preferred diagnostic laboratory.

Dear ErinDaugherty:

We enjoyed meeting with you at ACG todiscuss how Lactoferrin Qualitative andLactoferrin Quantitative testing and itsproven utility in helping you identify andmonitor inflammation.

If you haven’t already, please visit theTECHLAB website to register your testingfacility (licensed moderate or highcomplexity) or your preferred diagnosticlaboratory for a free Lactoferrin evaluationkit.

Learn more about our Lactoferrin diagnosticsfor intestinal inflammation.

Please contact us with technical questions orhow to include Lactoferrin testing at yourfacility or preferred diagnostic laboratory:[email protected].

Sincerely,Your friends at TECHLAB

QUALITATIVELACTOFERRIN TESTS

LEUKO EZ VUE® — Lateral flowformat for testing patients withacute, infectious bowel symptoms IBD EZ VUE® — Lateral flowformat for testing patients withchronic, non- infectious bowelsymptoms

IBD-CHEK® — ELISA format fortesting patients with chronic,non-infectious bowel symptoms

QUANTITATIVELACTOFERRIN TEST

IBD-SCAN® — ELISA format fortesting patients with chronic, non-infectious bowel symptoms or toassist in monitoring quantitativeinflammation levels in IBD patients

www.techlab.com | [email protected] TECHLAB Logo, and TECHLAB are trademarks of TECHLAB, Inc.

© 2014 TECHLAB, Inc. All rights reserved.

Subject: We talked Lactoferrin at ACG - Need a Lactoferrin voucher?

0LikeLike TweetTweet 0 ShareShare 0 0 0 SubscribeSubscribe

We talked Lactoferrin at ACG - Need a Lactoferrin voucher? http://app.getresponse.com/archive/erin_708957/We-talked-Lac...

1 of 2 11/25/14, 9:45 AM

FOLLOW-UP EMAILS sent to booth visitors reminded them of our products and provided handy on-line links.

PRODUCT DEMONSTRATION VIDEOS could be watched both at the booth and on-line.

AN UPDATED BROCHURE mailed to booth visitors highlighted TECHLAB’s connection with another well-known product on the cover.

USA TODAY ADVERTISING appealed directly to potential IBD and IBS patients and encouraged them to find out more about our products.

In early 2015, TECHLAB’s marketing team created a new campaign messaging and visual communications strategy for lactoferrin testing products based upon market research findings, choosing to promote “lactoferrin testing” as a brand in and of itself rather than merely promoting the individual lactoferrin products. This new approach allowed us to focus on the application of lactoferrin testing to new markets, such as physicians working with Clostridium difficile (CDI) patients, whereas previously the focus had been limited to IBD and IBS. TECHLAB’s marketing team positioned lactoferrin testing in the market as the reliable choice for getting a first read on intestinal inflammation.

As the only FDA-approved lactoferrin-based tests for intestinal inflammation, TECHLAB moved to capitalize on our unique market position by launching a rebrand of our IBD products. We first chose to rename the products to more prominently feature the lactoferrin biomarker. We also took the opportunity to completely redesign our packaging, establishing a strong, cohesive visual identity for the lactoferrin product line.

Lactoferrin Testing2015 Campaign

PRODUCT REBRANDING

REDESIGNED KIT BOXES visually unite lactoferrin products with color and shape while maintaining some product differentiators.

REBRANDED TEST CASSETTES in the case of the lateral flow format display the new name.

UPDATED INSTRUCTION CARDS inside the kit boxes make use of the new visual identity.

A DESIGNATED WEBSITE just for lactoferrin testing allows us to put our new messaging on-line.

REBRAND ANNOUNCEMENTS sent to all of our customers alerted them to the changing look and built anticipation for the new products.

LACTOFERRIN EZ VUE

T C

Date: April 21, 2015

IBD-SCAN®IBD EZ VUE® IBD-CHEK®

REBRAND ANNOUNCEMENTDear Valued Customer:

We are pleased to announce that we have rebranded the IBD-SCAN®, IBD EZ VUE® and IBD-CHEK® kits to better represent the biomarker underlying each assay—lactoferrin.

Rebrand Overview

Please note that this is strictly a graphic brand change; there are no changes to this product line’s functionality, test procedures, assay components or quality. No manufacturing changes other than labeling will be made to this product. No additional validation studies are required. These changes do not affect the performance or safety and effectiveness of the tests. The products’ assigned US FDA 510(k) numbers, catalog codes and pricing will not be modified.

When Does This Go Into Effect?

Rebranded IBD products will begin shipping in May 2015. Note, each rebranded product will begin shipping from the warehouses after all existing product stock is depleted; therefore, you may not begin to receive rebranded product until sometime in August 2015.

What Will The New Kit Names Be?

The new kit names will be LACTOFERRIN SCAN™, LACTOFERRIN EZ VUE™ and LACTOFERRIN CHEK™.

Previous Product Name Rebranded Product Name Catalog # US FDA 510(k) #

IBD-SCAN® LACTOFERRIN SCAN™ T5009 K042071

IBD EZ VUE® LACTOFERRIN EZ VUE™ T5018 K030704

IBD-CHEK® LACTOFERRIN CHEK™ T5008 K011396

How Will The New Branding Compare To The Previous Branding?

Here are some examples:

LACTOFERRIN SCANTM

T5009

An ELISA for the quantitative measurement of fecal lactoferrin

LACTOFERRIN SCAN™PREVIOUS BOX NEW BOX

LACTOFERRIN EZ VUE™ | Qualitative Lateral Flow

TEST PROCEDURE

INTERPRETATION

1 2 3 4Fill �ared tip with 50μL sample and add

to tube containing 2.5mL Diluent.

This chart does not contain the complete instructions for use of the LACTOFERRIN EZ VUE™ test. For proper use of the assay, please read the accompanying literature.

Add 2.5mL Diluent to a tube.

If there is no line at C(control) the test is invalid.

If there is no line at C(control) the test is invalid.

Add �lter tip to tube.

Vortex to mix.

Add 5 drops to Sample

Well. Read at 10 minutes.

LACTOFERRIN EZ VUE

LACTOFERRIN EZ VUE

POSITIVE

LACTOFERRIN EZ VUE

NEGATIVE

LACTOFERRIN EZ VUE

INVALID

LACTOFERRIN EZ VUE

INVALID

50 µL

100 µL

200 µL

300 µL

All Membrane Cassettes mustbe read promptly at 10 minutes.

A test result cannot be ruled negativeor invalid until promptly at 10 minutes.

Sample Well

Reaction Window

min30

min10

Made in the USA. © 2015 TECHLAB, Inc. All rights reserved. LACTOFERRIN EZ VUE, the TECHLAB Logo, and TECHLAB are trademarks of TECHLAB, Inc.

Developed and Manufactured by:

Blacksburg, VA 24060-6358, USA2001 Kraft Drive

Part No. 91-353-03Issued: 4/2015

Diagnosed C. difficile patientMeasuring lactoferrin levels can help to indicate the degree of CDI severity.

Diagnosed IBD patientMeasuring lactoferrin levels can help to indicate the degree of IBD severity.

TEC

HLA

B®

2001 Kraft D

rive

Blacksb

urg, VA 24060

US

A

Get a reliable first read on intestinal inflammation with

LACTOFERRIN TESTINGNON-INVASIVE ∙ SENSITIVE ∙ SPECIFIC ∙ COST-EFFECTIVE

Visit us at DDW® 2015 | BOOTH 3437 Find out more at lactoferrintesting.com

Suspected IBS/IBD patientDetecting elevated lactoferrin levels can help to differentiate active IBD from IBS.

Suspected C. difficile patientDetecting elevated lactoferrin levels can help to confirm the diagnosis of true CDI.

Let lactoferrin testing help in the diagnosis and treatment of IBS, IBD, and C. difficile

© 2015 TECHLAB, Inc. All rights reserved. All trademarks referenced are trademarks of TECHLAB, Inc.

A simple stool sample can speak volumes on intestinal inflammation



Brought to you by the developers of the trusted

C. DIFF QUIK CHEK COMPLETE® test

Visit us at DDW® 2015 | BOOTH 3437

DDW2015 Tradeshow

A POSTCARD MAILER sent to likely show participants ahead of the show introduced our new campaign (front and back of mailer shown here).

FULL PAGE ADVERTISEMENTS placed in the pre-show issues of leading academic journals and the DDW daily newspaper were designed to look like journal question and answer articles.

EXHIBIT GUIDE ADVERTISING also helped to drive traffic to our booth during the show.

TECHLAB’s DDW 2015 tradeshow was the first show to feature our rebranded lactoferrin products. We developed a message highlighting the reliability and non-invasiveness of lactoferrin testing and created a unique and compelling visual metaphor of lactoferrin’s clinical utility to apply to all of our marketing materials.

Q: What is Lactoferrin? A: Lactoferrin is a protein found in activated neutrophils (fecal leukocytes). When there is inflammation in the intestines, activated neutrophils will be shed into the stool. Thus, an elevated level of fecal lactoferrin indicates intestinal inflammation.

Q: What causes intestinal inflammation? A: Intestinal inflammation is caused by many different condi-tions. Two diseases are especially associated with inflammation. Inflammatory Bowel Disease (IBD) is the primary cause of noninfec-tious intestinal inflammation and can be difficult to distinguish from other intestinal disorders, especially Irritable Bowel Syndrome (IBS). Clostridium difficile disease, also referred to as C. difficile infection (CDI), is the primary cause of infec-tious intestinal inflammation.

Q: What is the role of fecal lactoferrin in diagnosing and managing intestinal inflammation? A: A positive test result for elevat-ed fecal lactoferrin in persons who have tested negative for infectious etiologies should alert the physician to possible IBD. A negative result may signal a functional disorder like IBS, which is non-inflammatory. Levels of fecal lactoferrin correlate with disease activity and may be used as an indicator of mucosal healing. C. difficile disease is complicated to diagnose because the presence of the organism does not always correlate with disease. In many instances, persons who are infected with C. difficile are simply carriers of the organism and do not need to be treated for CDI. Elevated fecal lactoferrin in persons who are positive for C. difficile and its toxins help identify the disease, and can indicate if the intestines have become inflamed. In both diseases, whether found separately or togeth-er (as is often the case), lactoferrin testing aids in determining disease severity and appropriate therapy.

Q: How does lactoferrin testing compare with other technologies? A: Lactoferrin is more stable in feces, exceeding all other FDA-cleared fecal biomarker assays.

Fecal lactoferrin can be accurately measured in specimens with levels remaining unchanged for up to 2 weeks when samples are stored at room temperature or in the refrigerator. This translates into

more reliable testing for intestinal inflammation.

Q: Are these tests reimbursable? A: Yes, lactoferrin testing is covered by most health insurance plans.

Q&A: Fecal Lactoferrin TestingADVERTORIAL

The TECHLAB Logo, and TECHLAB are trademarks of TECHLAB, Inc. © 2015 TECHLAB, Inc. All rights reserved.

A simple stool sample can speak volumes on intestinal inflammation



Visit us at DDW® 2015 | BOOTH 3437 Find out more at lactoferrintesting.com

As a result of our lactoferrin marketing campaign, product sales increased by 10% in 2015 over 2014.

A FUN CONTEST where delegates had to guess the number of little TECHLAB toilets in a huge container displayed in the main exhibition hall was met with great enthusiasm.

OUR 30-FOOT BOOTH was a show standout and drew big crowds each day. Four connected video screens presented lactoferrin testing information above large lightbox displays. A demonstration counter featured direct access to the lactoferrin testing website, allowing booth visitors to explore the site on their own. The main counter held various support collateral pieces that TECHLAB staff used to further explain the products and that visitors could then take away with them in their lactoferrin testing branded bags. The back wall and coffee table displayed the newly rebranded test kit boxes, allowing staff easy access to them to show prospective clients.

Our new campaign generated a record number of new leads at DDW—more than double that of the previous year.

A FOURTEEN-PAGE BROCHURE included in the DDW registration welcome bag and also made available at the booth provided an overview of lactoferrin testing, its clinical advantages, types of testing formats available, and ordering tips.

LARGE, COLORFUL BAGS sporting the lactoferrin branding were given out at the booth to hold all of the lactoferrin collateral. The large bag size allowed it to also carry show collateral from other booths, resulting in our bag becoming the most visible carryall at the show.

NON-INVASIVE ∙ SENSITIVE ∙ SPECIFIC ∙ COST-EFFECTIVE


LACTOFERRIN TESTING

lactoferrintesting.com

IBS IBD CDI

Assists in the diagnosis and monitoring of

TECHNICAL MONOGRAPHS explaining the science behind the lactoferrin testing and its clinical utility in IBS/IBD patient care, as well as in the care of C. difficile patients, were introduced at this year’s show and were very well received by physicians and laboratory professionals.

Discover the benefits of TECHLAB’s on-site product support and technical consultants

Our established network of product consultants can provide technical training and operational support of enteric diagnostics for routine use in your laboratory. Dedicated to facilitating the implementation of new assays, these consultants will offer effective training to help speed up the validation process of new test methods for use. Expertise is offered on the evaluation and review of data from a laboratory perspective. Our product support team is dedicated to helping achieve efficiency and excellence in your clinical practice.

Actual reimbursement may vary. TECHLAB cannot guarantee or promise coverage or payment for any particular item or service from any payer or health

benefit plan. It is the individual provider’s responsibility to determine appropriate coding for a particular service.

Made in the U.S.A.

All products referenced, the TECHLAB Logo, and TECHLAB are trademarks of TECHLAB, Inc., under license. © 2015 TECHLAB, Inc. All rights reserved.

LACTOFERRIN EZ VUE®

Moderately Complex25 Test KitOrder Number: 30353 CPT® Code: 83630

LACTOFERRIN SCAN®


LACTOFERRIN CHEK®


Let LACTOFERRIN TESTING from TECHLAB®

enhance your routine diagnostics. Find out how today.

CONTACT US:

Phone:1-800-TECHLAB (in US)

+1-540-953-1664 (outside US)

Online:lactoferrintesting.com

E-mail:[email protected]

A LACTOFERRIN PRODUCT SUPPORT SHEET proved helpful in closing the sale by promoting our technical product support services, giving interested potential clients the information required to easily order the right products for their needs, and providing handy contact information.

INFECTIOUS DISEASE PRODUCT MARKETING

Visit us at ASTMH 2014 BOOTH 113

Infectious Disease DIAGNOSTICS FOR GLOBAL HEALTH

RAPID RESULTS • HIGH SENSITIVITY • HIGH SPECIFICITY

E. HISTOLYTICA QUIK CHEK™

The first rapid test to distinguish E. histolytica from non-pathogenic E. dispar

GIARDIA/CRYPTOSPORIDIUM QUIK CHEK

Highly sensitive detection of the two most common waterborne intestinal parasites from a single fecal sample

SHIGA TOXIN QUIK CHEKThe only rapid test able to detect Shiga toxin-producing E. coli/verotoxin-producing E. coli directly from fecal samples

LEUKO EZ VUE®

Accurate, non-subjective laboratory results for fecal lactoferrin and intestinal inflammation

Distributed by:

Developed & manufactured by:


www.techlab.com

,


E. HISTOLYTICA QUIK CHEK™

The �rst rapid test to distinguish E. histolytica from non-pathogenic E. dispar

GIARDIA/CRYPTOSPORIDIUM QUIK CHEKHighly sensitive detection of the two most common waterborne intestinal parasites from a single fecal sample

SHIGA TOXIN QUIK CHEKThe only rapid test able to detect Shiga toxin-producing E. coli/verotoxin-producing E. coli directly from fecal samples

LEUKO EZ VUE®

Accurate, non-subjective laboratory results for fecal lactoferrin and intestinal in�ammation

E. HISTOLYTICA

E. HISTOLYTICA

EntericDiagnostics

Malnutrition

IntestinalIn�ammation

MultiplexScreening

TravelerHealth

RapidResults

GIARDIA/CRYPTO

HighSensitivity

GIARDIA/CRYPTO SHIGA TOXIN

SHIGA TOXIN

HighSpeci�city

LEUKO EZ VUE

LEUKO EZ VUE

InfectiousDisease

DIAGNOSTICSFOR GLOBAL

HEALTH

ASTMH2014 Tradeshow

To appeal to the international audience at ASTMH, TECHLAB featured four of our rapid QUIK CHEK™ and lateral flow test kits for infectious disease and touted our international collaborations.

TECHLAB®, Inc. partners with health research organizations to make our products avail-able for clinical and epidemiological studies of diarrheal diseases.

Bill & Melinda Gates FoundationWith a grant from the Bill & Melinda Gates Foundation, the University of Maryland School of Medicine’s Center for Vaccine Development used TECHLAB diagnostics for a three-year study of diarrheal diseases among young children in developing areas of Africa and Asia. The Global Enteric Multi-Center Study (GEMS) is the most extensive study of child-hood diarrheal diseases ever conducted, with more than 22,000 subjects from seven sites. Researchers evaluated approximately 40 pathogens to determine the most com-mon causes of moderate-to-severe diarrheal disease.

National Institutes of Health (NIH)Using small business grants obtained through the National Institute of Allergy and Infec-tious Diseases (NIAID) and the Middle Atlantic Center of Excellence (MARCE), TECHLAB and its research collaborators have effectively moved medical diagnostics from concept to the international marketplace. TECHLAB has partnered over the past 15 years with Dr. William A. Petri, Jr. at the University of Virginia and Dr. Rashidul Haque at the International Centre for Diarrhoeal Disease Research in Bangladesh to secure NIH development funds for global diagnostics.

TECHLAB strives to build long-term partnerships that create successful outcomes lead-ing to better patient healthcare.

TECHLAB Senior Research Scientist, Dr. Joel Herbein, visits Bamako, Mali to lead enteric parasitology diagnostic training at the Center for Vaccine Development Mali study site.

Infectious Disease COLLABORATIONS THAT SUCCEED


POSTCARD MAILERS sent to likely show participants before the show promoted the products to be featured and invited participants to the booth.

A CUSTOM DESIGNED 20-FOOT BOOTH provided an integrated video monitor and numerous product and information display areas.

VIDEOS detailing our products and our work in developing countries played continuously at the booth.

SIGNAGE greeted counter visitors and told the story of TECHLAB’s collaboration with both the Bill & Melinda Gates Foundation and NIH.

PRODUCT DEMONSTRATION VIDEOS detailing the correct use of each test kit could be viewed at the booth and also on-line after.

FOLLOW-UP EMAILS sent after the show to booth visitors helped to remind participants of TECHLAB products and provide convenient on-line links to ordering information.

ECCMID2015 Tradeshow

TECHLAB focused on promoting our QUIK CHEK™ product portfolio for infectious disease at the 2015 ECCMID tradeshow. We chose “Rapid, high-performance diagnostics for global health” as our main marketing message.

We custom-built a brand new, 30-foot with two QUIK CHEK™ cassette shapes flanking an enormous video wall. The booth also featured two free-standing lightboxes that displayed product messaging and test kit boxes, a product demonstration video counter, a reception counter holding printed collateral, a seating area, and fun, branded giveaway items.

RENDIMIENTO PROBADO EN EL DIAGNÓSTICO DE ENFERMEDADES GASTROINTESTINALES

¿Hasta qué punto es equiparable la tecnología de ELISA rápida de QUIK CHEK™ con el flujo lateral?

frente a

QUIK CHEK™ | Flujo lateral

ELISA rápida: QUIK CHECK™

Flujo lateral

Proceso El contacto entre una almohadilla y una membrana porosas permite la difusión eficiente y la formación de complejos antígeno-anticuerpo. Mediante la detección enzimática se logra un aumento de la sensibilidad.

Los antígenos interactúan con los anticuerpos fijados al látex o a las partículas de oro que se capturan en la línea de prueba para formar una línea coloreada.

¿Es necesario un flujo uniforme?

No Sí

¿Hasta qué punto son fiables los resultados?

Un paso de lavado garantiza que el material no unido se retire de la línea de prueba, lo que reduce las interferencias y amplifica el resultado de la prueba.

Sin el paso de lavado, el material no unido no puede retirarse de la línea de prueba, lo que da lugar a una prueba supeditada a obstrucciones que arroja resultados imprecisos o no concluyentes.

How does QUIK CHEK™ rapid ELISA technology compare to lateral flow?

What is the process?

Does it require a uniform flow?

How reliable are results?

QUIK CHEK™

Contact between a porous pad and a porous mem-brane enable the efficient diffusion and formation of antigen-antibody complexes. Increased sensitivity is achieved by enzymatic detection.

No

A wash step ensuresunbound material isremoved from the testline, minimizing interfer-ence and amplifying the test result.

Lateral Flow

Antigens interact with antibodies attachedto latex or gold particles that are captured at the test line to form a colored line.

Yes

With no wash step, unbound material may not be removed from the test line, leaving the test subject to clogs that result in inconclusive or inaccurate results.

QUIK CHEK™ | Lateral Flow

vs

A HANDY COMPARISON CARD produced in both English and Spanish explained the differences between QUIK CHEK™ and lateral flow technologies.

A VIDEO playing continuously at the booth also explored the differences between QUIK CHEK™ and lateral flow technologies with clever animations.

Rapid, High-Performance Diagnostics for Global HealthQUIK CHEK™

Distributed by:

Developed and Manufactured by:

Literature List

Data from package insert (n=1126). Further testing may assist diagnosis.

A COMPREHENSIVE Algorithm for C. difficile Testing

+ LACTOFERRIN TESTING

for Inflammation

www.techlab.com

Testing AlgorithmC. DIFF QUIK CHEK COMPLETE®

13% GDH + Toxin +

77% GDH - Toxin -

LACTOFERRIN TESTING FOR INFLAMMATION

TO DETERMINE SEVERITY

10% GDH + Toxin -

90% of samples

“Diarrhea and the presence of C. difficile in the stool are associated with intestinal inflammation, as detected by fecal lactoferrin.”L.R. Archbald-Pannone, J.E. Sevilleja, R.L. Guerrant. Diarrhea, Clostridium difficile, and intestinal inflammation in residents of a long-term care facility.2010. J Am Med Dir Assoc. 11 (4): 263-7

“In conclusion, CDI PCR-positive patients with 027 infection and stool toxin have increased lactoferrin and are at increased risk of death.”J.H. Boone, L.R. Archibald-Pannone, K.N. Wickham, R.J. Carman, R.L. Guerrant, C.T. Franck, D.M. Lyerly.Ribotype 027 Clostridium difficile infections with measurable stool toxin have increased lactoferrin and are associated with a higher mortality.2014. Eur J Clin Microbial Infect Dis. 33 (6): 1045-51

“Our findings show that elevated lactoferrin, along with increased WBC count and low serum albumin, were associated with more severe CDI.”J.H. Boone, J.R. DiPersio, M.J. Tan, S.J. Salstrom, K.N. Wickham, R.J. Carman, H.R. Totty, R.E. Albert, D.M. Lyerly.Elevated lactoferrin is associated with moderate to servere Clostridium difficile disease, stool toxin, and 027 infections.2013. Eur J Clin Microbiol Infect Dis. 32: 1517 – 1523

“Differences in fecal lactoferrin levels suggest variable presence or severity of C. difficile infection among toxin+ and toxin- patients.”P.R. LaSala, T. Eckhmimi, A.K. Hill, I. Farooqi, P.L. Perrotta.Quantitative fecal lactoferrin in toxin-positive and toxin-negative Clostridium difficile specimens.2012. J. Clin Microbiol. DOI:10.1128/JCM.02735-12

“Lactoferrin appears to be a useful marker for the presence of inflammatory diarrhea.” M.W.D. Wren, M. Sivapalan, R. Kinson, N.P. Shetty.Laboratory diagnosis of Clostridium difficile infection. An evaluation of tests for faecal toxin, glutamate dehydrogenase, lactoferrin and toxigenicculture in the diagnostics laboratory.2008. Br J Biomed Sci. 661 (1): 1-5

“We report that higher levels of intestinal inflammation, as measured by quantitative fecal lactoferrin, are associated with moxifloxacin-resistant CDI.”S.W. Pawlowski, L. Archbald-Pannone, R.J. Carman, C. Alcantara-Warren, D. Lyerly, C.W. Genheimer, D.N. Gerding, R.L. Guerrant.Elevated levels of intestinal inflammation in Clostridium difficile infection associated with fluoroquinolone-resistant C. difficile.2009. J Hosp Infect. 73 (2): 185-187.

“Fecal interleukin (IL)-8 and lactoferrin are also elevated in vivo, in patients with severe CDI.”R.E. El Feghaly, J.L. Stauber, E. Deych, C. Gonzalez, P.l. Tarr, D.B. Haslam.Markers of intestinal inflammation, not bacterial burden, correlate with clinical outcomes in Clostridium difficile infection.2013. Clinical Infectious Diseases 56 (12): 1713-21

Session O062: Severity and outcome parameters of Clostridium difficile infections based on toxin, toxin-gene and lactoferrin testing in stools. Presentation is scheduled for the oral session Pioneering diagnostics: beyond genomics and MALDI-TOF

Date and Time: 26 April 2015 from 11:42am-11:54am

Venue: Hall F

Presenter: Lutz Von Mueller

ePoster EV0544: Evaluation of the new SHIGA TOXIN QUIK CHEK™ membrane enzyme immunoassay for the direct detection of STEC in stool specimens and enrichment broth

Authors: Eigner Ulrich, Anke Veldenzer, Rosemarie Schwarz, Martin Holfelder

Viewing Station: Diagnostic/laboratory methods other than molecular

ePoster LBEV0584a: Evaluation of E. HISTOLYTICA QUIK CHEK™: The first rapid diagnostic test specific for the detection of pathogenic Entamoeba histolytica in human faecal specimens

Authors: Hencke, Verkerke, Siddique, Hanbury, Haque, Petri, Herbein

Viewing Station: Diagnostic/laboratory methods other than molecular

KEY SESSIONS & ePOSTERS

Rapid, High-Performance Diagnostics for Global HealthQUIK CHEK™

MULTI PURPOSE BOOKMARKS designed for insertion in the exhibit guide provided both information on TECHLAB’s key sessions and e-posters and useful lined space for notes on the reverse side.

PRODUCT INFORMATION SHEETS showing a comprehensive algorithm for C. difficile testing through the combined use of C. DIFF QUIK CHEK COMPLETE® and lactoferrin testing were given out at the booth.

A BRANDED DANCING ROBOT giveaway item proved to be a huge crowd pleaser and drew many people to the booth via word of mouth from other booth visitors.

LARGE, BRANDED BAGS provided great exposure to our show messaging as participants carried it throughout the exhibit hall.

PROJECT TECHLAB 10x30 ASM exhibit concept - view 1

ASM2015 Tradeshow

At the 2015 ASM tradeshow, TECHLAB promoted four of our rapid QUIK CHEK™ and lateral flow test kits for infectious disease at our booth and highlighted SHIGA TOXIN QUIK CHEK™ in our marketing collateral.

A CUSTOM DESIGNED 30-FOOT BOOTH had a four-screen integrated video display, large panels for product messaging, an attractive seating area, and a welcome counter designed to hold printed collateral pieces and touchscreen displays.

POSTCARD MAILERS sent to expected show participants ahead of the show promoted the comparative advantages of SHIGA TOXIN QUIK CHEK™ over the competitor and promoted our booth number and website.

PRODUCT SELL SHEETS were available at the booth to take away.

LARGE, BRANDED BAGS given out at the booth held our collateral and also collateral from other booths.

A FOUR-SCREEN VIDEO played continuously at the booth, detailing product features and benefits.

Infectious Disease?Better to Know Earlier.

Broth culture results that are twice as sensitive

SHIGA TOXIN QUIK CHEK™

Don’t doubt your STEC broth culture result. Detect more true positives with the

TECHLAB® SHIGA TOXIN QUIK CHEK™ test.



Leading EHEC Test

85.0%1

100.0%1

35.3%2

54.5%2

Clinical Sensitivity

Positive Predictive Value

The above clinical results were obtained by testing broth cultures and comparison to real-time PCR.

REFERENCES:1 L. Chui, L. Patterson-Fortin, J. Kuo, V. Li, V. Boras. 2015. Evaluation of enzyme immunoassays and real-time PCR for detecting Shiga toxin-producing Escherichia coli in Southern Alberta, Canada. J Clin Microbiol. 53(3):1019-23.2 L. Chui, M.C. Lee, R. Allen, A. Bryks, L. Haines, V. Boras. 2013. Comparisons between ImmunoCard STAT!® and real-time PCR as screening tools for both O157:H7 and non-O157 Shiga toxin-producing Escherichia coli in Southern Alberta, Canada. Diagn Microbiol Infect Dis. 77(1):8-13.

Distributed by:

Developed & Manufactured by:

Find out more at techlab.com

asm2015 | BOOTH 752



Don’t doubt your STEC broth culture result.

Detect more true positives with the TECHLAB®

SHIGA TOXIN QUIK CHEK™ test.


Distributed by:

Developed & Manufactured by:

The Enterics Suite of Rapid Diagnostics


For more information or to order, contact your Cardinal Health sales representative, call 1-800-964-5227 or visit cardinalhealth.com


REFERENCES:

1 L. Chui, L. Patterson-Fortin, J. Kuo, V. Li, V. Boras. 2015. Evaluation of enzyme immunoassays and real-time PCR for detecting Shiga toxin-producing Escherichia coli in Southern Alberta, Canada. J Clin Microbiol. 53(3):1019-23.2 L. Chui, M.C. Lee, R. Allen, A. Bryks, L. Haines, V. Boras. 2013. Comparisons between ImmunoCard STAT!® and real-time PCR as screening tools for both O157:H7 and non-O157 Shiga toxin-producing Escherichia coli in Southern Alberta, Canada. Diagn Microbiol Infect Dis. 77(1):8-13.

Don’t doubt your STEC broth culture result. Detect more true positives with the

TECHLAB® SHIGA TOXIN QUIK CHEK™ test.


Leading EHEC Test

85.0%1

100.0%1

35.3%2

54.5%2

Clinical Sensitivity

Positive Predictive Value


The above clinical results were obtained by testing broth cultures and comparison to real-time PCR.

TECHLAB GENERAL & CORPORATE MARKETING

A website is a crucial component to any business. Prospective clients, employees, and partners make critical decisions about whether to work with a company using just the information provided on a website. TECHLAB’s site is comprehensive and covers all aspects of our business.

Our website offers:• Clear, comprehensive information

about our products and a variety of purchasing options.

• A comprehensive digital library of current clinical data and research.

• Information about the services we provide beyond developing diagnostic tests, like research testing and medical device manufacturing.

• Demonstrations of the innovations we make in the diagnosis of intestinal diseases.

Corporate Website

TECHLAB produces a quick product reference guide that allows laboratory and clinical professionals easy access to important information about our complete product line.

OUR PRODUCT CATALOG is organized to maximize the quick identification of essential information about each test we offer, including broad category of diagnostic kit, catalog number, suggested CPT code, number of tests per kit, analytes detected, format, time to results, and specimen requirements. It is an invaluable sales tool.

Catalog

SPRING 2014

SPECIAL

25TH ANNIVERSARY

ISSUE

An irregular publication of TECHLAB,® Inc. dedicated to the etiology, diagnosis, and therapy of diarrheal diseases and related

aspects of intestinal ecology

INSIDE

Experts Weigh In on Fecal LactoferrinTaking on the Challenge of C. Diff

Testing for the Big 3 ParasitesDetecting Shiga Toxin

…and more

PLUS our ever popular stool notes

Brought to you by the makers of the enteric suite of rapid diagnostics

C

LEUKO EZ VUE

T

C

LEUKO EZ VUE

T

C

Ag Tox

C. DIFF COMPLETE

C

Ag Tox

C. DIFF COMPLETE

C

Cryp Giar

QUIK CHEK

C

Cryp Giar

QUIK CHEK

C

1 2

SHIGA TOXIN

C

1 2

SHIGA TOXIN


[email protected] | www.techlab.com

SPRING 2015

POOP CULTURENorovirus &

Gut Flora

An irregular publication of TECHLAB®, Inc. dedicated to the etiology, diagnosis, and therapy of diarrheal diseases and related

aspects of intestinal ecology

INSIDETECHLAB Diagnostics Go Global

Fecal Lactoferrin & C. difficilePaleopathology News

Brought to you by the makers of the enteric suite of rapid diagnostics


NEW FRONTIERS: FECAL LACTOFERRIN TESTING & C. DIFFICILE

TECHLAB produces Diarrhea Digest twice annually. This newsletter-style publication has been a smash hit at tradeshows and highlights developments in enterics with a splash of humor.

Diarrhea Digest

THE SPRING 2015 EDITION of Diarrhea Digest, like all issues, blends the humorous with the serious. Our back page, called “Poop Culture” features funny cartoons, amusing on-line links, trivia, quizzes, and more, while the proceeding pages focus on developments in intestinal disease diagnostics.

TECHLAB partners with health research organizations to make our products available for clinical and epidemiological studies of diarrheal diseases.

With a grant from the Bill & Melinda Gates Foundation, the University of Maryland School of Medicine’s Center for Vaccine Development used TECHLAB diagnostics for a three-year study of diarrheal diseases among young children in developing areas of Africa and Asia.

TECHLAB has also supplied diagnostics tests to the Global Enteric Multi-Center Study (GEMS), the most extensive study of childhood diarrheal diseases ever conducted, and to The International Centre for Diarrhoeal Disease Research—a health research institution in Dhaka, Bangladesh.

The Global Enteric Multi-Center Study (GEMS) is the most extensive study of childhood diarrheal diseases ever conducted, with more than 22,000 subjects from seven sites. Researchers evaluated about 40 pathogens to determine the most common causes of diarrheal diseases.

October 31, 2014

Bill and Melinda GatesCo-Chairs, Bill and Melinda Gates Foundation500 Fifth Avenue NorthSeattle, WA 98109

Dear Mr. and Ms. Gates:

On behalf of the owners and employees of TECHLAB, Inc., we cordially invite you to visit TECHLAB’s exhibit at the 63rd Annual Meeting of The American Society of Tropical Medicine and Hygiene held in New Orleans between November 2-5, 2014.

TECHLAB’s theme for this year’s meeting is “Infectious Disease Diagnostics for Global Health.” In part, this celebrates productive collaborations between the Bill and Melinda Gates Foundation and TECHLAB over the last decade. These collaborations include the following:

• Utilization of TECHLAB’s enteric parasitology diagnostics in the Foundation’s GEMS project. Importantly, GEMS documented a previously unknown level of mortality due to cryptosporidiosis.

• Participation in the Foundation’s MAL-ED project, both with enteric parasitology diagnostics and biomarker assays that quantify intestinal inflammation in malnourished children.

• Involvement in the Foundation’s vaccine efficacy study, PROVIDE. TECHLAB partnered with Dr. William A. Petri, Jr. at the University of Virginia to develop a novel biomarker assay that describes the burden of tropical enteropathy in vaccine non-responders.

• Ongoing product development associated with the Foundation’s RIAT project that funds new diagnostic assays to describe population-level success of vaccination campaigns.

• Participation in the Foundation’s newly formed Cryptosporidium intervention initiative.

The Bill and Melinda Gates Foundation has allowed TECHLAB to employ our strengths towards improving global health; we look forward to expanding these collaborations in the near future.

We certainly understand that you have a very busy schedule. If the opportunity arises, however, we would enjoy having you and your colleagues visit our ASTMH exhibit at BOOTH #113.

Sincerely,

Joel Herbein, PhD David Lyerly, PhDSenior Research Scientist Vice President of Research and DevelopmentDirector, Veterinary Products Co-Owner540-449-4556 (mobile)[email protected]


2001 Kraft Drive | Blacksburg, VA 24060-6358 | T: (540) 953-1664 | F: (540) 953-1665 | www.techlab.com | [email protected]


INVITATION TO THE GATES FOUNDATION to visit the TECHLAB booth at ASTMH 2014.

A MAP showing the usage of TECHLAB’s parasitology products around the world.

RESEARCHERS AND STUDY PARTICIPANTS from projects in Bangladesh and Mali.

International Collaborations & Grant Funded Clinical Studies

Running a business and providing employment allows us to connect and contribute to the New River Valley, the beautiful place TECHLAB is proud to call home. Beyond day-to-day business, TECHLAB is always looking for ways to reach out and connect with the local community.

Community Relations

IN OCTOBER 2014, TECHLAB PARTICIPATED IN VIRGINIA’S FIRST ANNUAL SCIENCE FESTIVAL WEEK by holding an open house for local science teachers. The event allowed TECHLAB researchers to show teachers how scientific principles are used to develop medical diagnostic products. (far left)

TECHLAB SPONSORED TEAM ‘WalkScan’ from Australia during Virginia Tech Knowledge Works Global Challenge in August. (near left)

TECHLAB RESEARCHERS PRESENTED DATA at the VaBio Poster Session. (far and near left)

NRVNEWS.COM, a local news outlet, covered the release of our newest product last fall, the E. Histolytica QUIK CHEK.

THE ROANOKE TIMES ONLINE COVERAGE of our Fall 2014 BioTeach event.

News coverage helps to build strong community ties and fosters a sense of pride among TECHLAB employees. When regional news outlets cover TECHLAB efforts, they help us to share the stories beyond our product lines.

THE AWARD-WINNING REGIONAL MAGAZINE THE ROANOKER featured TECHLAB in an article about businesses with global reach located in the Roanoke and New River Valleys.

Regional Press

Increasing brand recognition in a competitive marketplace is not easy. We put our logo on give-away products that last, like cloth bags, t-shirts, and tumblers, and fun items, like squishy toilets, to connect, create a dialog, and resonate with our customers.

Promotional Items

MISCELLANEOUS ITEMS including our popular 25th anniversary t-shirt, mesh bag, and tumbler.

OUR CUSTOM TUMBLER is appreciated by our customers and our staff alike.

A REUSABLE MESH BAG is a popular giveaway at events.

OUR BRANDED SQUISHY TOILET has been a smash hit at trade shows and features our “unofficial” tagline: #1 in the #2 business.

karen clint marketing portfolio

Documents